6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

1

Illumina, Inc.

.::. a decade of beads .::.

.::. a handful of lessons .::.

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

2

Illumina, Inc. – The Big Picture

• So where did the technology and the company come from? And why is it unique?

– Technology derived from an academic chemistry laboratory

• What lessons can we as scientists learn from the Illumina story?

– Development of Illumina’s technology teaches scientists commercialization lessons of their inventions

• What lessons can those in policy-making positions learn from this story?

– Case study illustrates the intentions of the Bayh-Dole Act of 1980

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

3

What is Illumina today?

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

4

Technological Applications

• SNP Genotyping

• Gene Expression

• Proteomics

• Drug/pharmaceutical screening

• Chemical/odor sensing

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

5

Illumina Partnerships• GlaxoSmithKline, PLC• ChevronTexaco Energy/Research• Genome Quebec Innovation Centre• The Wellcome Trust Sanger Institute• National Center Biochip Technology• Johns Hopkins University• Whitehead Institute• University of Tokyo• Centre National de Genotypage• University of Southern California• University of California, Los Angeles• Genomas, Inc.• The Wellcome Trust Sanger Institute• Galileo Genomics, Inc. / Genzion Biosciences, Inc.• North American Rheumatoid Arthritis Consortium• Invitrogen, Inc.• National Cancer Institute• Max-Planck Institute of Psychiatry• PARC Team• PharmacoDesign• Cancer Research UK: Edinburgh University Colon Cancer

Genetics Group; Institute of Cancer Research; Cancer Research UK London Research Institute

• Aviagen, Inc.• North Shore-Long Island Jewish Health System• University of Pennsylvania, the Broad Institute, the CARe

Consortium

• SAIC-Frederick, Inc.• Center for Inherited Disease Research (CIDR) • Shafallah Center• deCODE• The Children's Hospital of Philadelphia• Johnson & Johnson Pharmaceutical R&D, LLC• ReaMetrix• Massachusetts General Hospital; Harvard Medical School• The United States Department of Agriculture (USDA)

Agricultural Research Service (ARS), the University of Missouri-Columbia (MU) and the University of Alberta (UA)

• MicroArray Quality Control (MAQC) project: FDA, NIH, EPA and USDA

• Duke University• Top 5 Pharmaceutical companies• Amgen / Brigham & Women's Hospital• Erasmus MC• The Genome Institute of Singapore• Children's Hospital of Eastern Ontario• Mayo Clinic• Asuragen• deCODE• National Genome Research Network• Golden Helix• IntegraGen• National Institute of Genomic Medicine (INMEGEN)• SNP Genetics

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

6

So where did it all begin?

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

7

David Walt, Ph.D.Department of Chemistry

Tufts University

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

8

Technological Origins

Covalentattachment

Sensor

Single opticalfiber

to camerafor detection

Target

Major limitation: ONE sensor per fiber optic cable

to camerafor detection

to camerafor detection

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

9

Bundled optical fiber

Technological Development

Single optical fiber Pointed optical fiber

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

10

Optical fiber with wells…

… and BEADS!Images courtesy of David R. Walt, PhD

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

11

BeadArray Technology

Generation of random arrays

Binding changes dye color of bead

Pools of beads

Fluorescent light signals to detector

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

12

Chronology of Key Events

96 97 98 99 00 01 02 03 04 05 06 07

Beads in wells

Pittsburgh Conference

Series A financing

Series B financing

Series C financingIPO raises $103 Million

Illumina founded

nGenetics acquired

FastTrack Genotyping

HapMap Project

Spyder acquired

CyVera acquired

Solexa merger

1M SNP BeadChip

Tec

hn

olo

gy

Fin

ance

Bu

s in

e ss

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

13

Things to consider1. This is a story about a company with unique technology

2. That technology was developed by a researcher• Hero story• Balance of Open Science Norms and Commercialization

3. Many factors impacted the success of the researcher, the technology and the company:

• Knowledge of IP

• Timing• Industrial partnerships• Due diligence on many fronts• Technology transfer

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

14

What does this mean for YOU?

• Performing open academic science and commercializing your inventions is possible

• Knowledge of intellectual property is the vehicle

• Realistic expectations is a requirement

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

15

Acknowledgements

Center for Genome Ethics, Law & Policy

• Bob Cook-Deegan, MD• Subhashini Chandrasekharan, PhD

Master’s Committee• Hunt Willard, PhD• Fred Dietrich, PhD

Fuqua School of Business• Ronnie Chatterji, PhD

Columbia University – School of Public Policy

• Bhaven Sampat, PhD

Tufts University• David Walt, PhD• Peggy Newell, Vice Provost• Martin Son, OTLIC• Nina Green, Director, OTLIC

Illumina, Inc.• John Stuelpnagel, DVM• Todd Dickinson, PhD• Maurissa Bornstein

BioVenture Investors• Marc Goldberg

6 October 2007 Illumina, Inc. - IGSP TalkDeirdre B. Parsons

16

C

GA